Jennifer McGill
Physician Assistant · Bemidji, MNNPI 1881730752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 692 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $4,091 and has fallen 97.6% since, to $98 in 2025. Among physician assistant clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 692 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$3K
- Johnson & Johnson$1K
- Lilly USA, LLC$1K
- GSK$917
- Pfizer$889
- plus $4K from 20 others
What the payments were for
- Food & beverage$13,59999%
- Education$1451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 159 | $3,003 |
| Amgen(2 entities) | 139 | $2,694 |
| Johnson & Johnson | 66 | $1,117 |
| Lilly USA, LLC | 63 | $1,103 |
| GSK | 48 | $917 |
| Pfizer | 54 | $889 |
| AstraZeneca(2 entities) | 24 | $827 |
| UCB, Inc. | 23 | $728 |
| Novartis | 44 | $664 |
| Sanofi | 6 | $328 |
| Aurinia Pharma U.S., Inc. | 10 | $277 |
| ANI Pharmaceuticals, Inc. | 12 | $196 |
| Actelion Pharmaceuticals US, Inc. | 3 | $180 |
| Radius Health, Inc. | 9 | $172 |
| Teva Pharmaceuticals USA, Inc. | 7 | $144 |
| E.r. Squibb & Sons, L.L.C. | 5 | $89 |
| Mallinckrodt Hospital Products Inc. | 3 | $70 |
| Ultragenyx Pharmaceutical Inc. | 4 | $65 |
| Fresenius Kabi USA, LLC | 3 | $58 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Kyowa Kirin, Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $47 |
| Nevro Corp. | 1 | $20 |
| Organon | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Janssen Scientific Affairs, LLC | 2 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,744 in reported general payments places this provider in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $247,184 |
| OtezlaApremilast | 23 | $155,868 |
| Hydroxychloroquine Sulfate | 366 | $15,660 |
| MethotrexateMethotrexate Sodium | 317 | $8,089 |
| Leflunomide | 114 | $7,614 |
| Restasis MultidoseCyclosporine | 11 | $7,276 |
| Pilocarpine Hcl | 39 | $3,772 |
| Colchicine | 42 | $3,403 |
| Duloxetine Hcl | 146 | $3,337 |
| Sulfasalazine | 109 | $3,278 |
| Cevimeline Hcl | 14 | $3,121 |
| Celecoxib | 127 | $2,606 |
| Prednisone | 314 | $2,564 |
| Mycophenolate Mofetil | 37 | $1,767 |
| Gabapentin | 102 | $1,641 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $2,694 | $155,86823 claims |
| AbbVieRestasis Multidose | $3,003 | $7,27611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Other physician assistant in Bemidji
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
- Sarah SchettleRochester$150K
- John IsenbergMaple Grove$92K
- Kenneth MitchellWoodbury$87K
- Jennifer SutherlandMinneapolis$65K
- George FroehleMinneapolis$61K
- Skye PeltierMinneapolis$33K
- Devanie SutterSt Louis Park$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.